Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
ARDM Aradigm		$0.24	$0.07 ▼ $2.33	$761K	1.57	97,091 shs	N/A
CUTR Cutera	$0.04 -63.9%	$0.04	$0.09 ▼ $1.87	$787K	1.36	2.65 million shs	27.70 million shs
NDRA ENDRA Life Sciences	$3.43 -0.6%	$3.93	$2.90 ▼ $286.48	$2.53M	-0.21	141,403 shs	10,761 shs
NUWE Nuwellis	$0.29 +3.5%	$0.84	$0.21 ▼ $8.23	$1.26M	0.48	3.22 million shs	3.50 million shs

A Beginner's Guide to Investing in Cannabis

Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
ARDM Aradigm	0.00%	0.00%	0.00%	0.00%	0.00%
CUTR Cutera	0.00%	0.00%	0.00%	0.00%	-97.86%
NDRA ENDRA Life Sciences	0.00%	+2.68%	+6.81%	-16.06%	-99.96%
NUWE Nuwellis	0.00%	-30.76%	-70.33%	-75.94%	-95.91%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
ARDM Aradigm	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
CUTR Cutera	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
NDRA ENDRA Life Sciences	2.7224 of 5 stars	3.5	4.0	0.0	0.0	2.2	0.0	1.3
NUWE Nuwellis	3.0782 of 5 stars	3.5	5.0	0.0	0.0	2.4	0.0	1.3

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
ARDM Aradigm	0.00	N/A	N/A	N/A
CUTR Cutera	2.50	Moderate Buy	$3.00	7,592.31% Upside
NDRA ENDRA Life Sciences	3.00	Buy	$50.00	1,357.73% Upside
NUWE Nuwellis	3.00	Buy	$17.00	5,782.35% Upside

Current Analyst Ratings Breakdown

Latest ARDM, NDRA, NUWE, and CUTR Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target	Details
5/13/2025	NUWE Nuwellis	Roth Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy
4/21/2025	NDRA ENDRA Life Sciences	Ascendiant Capital Markets Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Buy ➝ Buy	$75.00 ➝ $50.00

(Data available from 6/16/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
ARDM Aradigm	$14.47M	0.00	N/A	N/A	($0.83) per share	0.00
CUTR Cutera	$155.21M	0.01	N/A	N/A	($8.62) per share	0.00
NDRA ENDRA Life Sciences	N/A	N/A	N/A	N/A	$1,170.18 per share	N/A
NUWE Nuwellis	$8.79M	0.14	N/A	N/A	$18.40 per share	0.02

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
ARDM Aradigm	-$10.70M	-$0.72	N/A	N/A	N/A	-374.80%	N/A	-374.15%	N/A
CUTR Cutera	-$162.83M	-$6.58	N/A	N/A	N/A	-84.86%	N/A	-45.07%	8/6/2025 (Estimated)
NDRA ENDRA Life Sciences	-$10.06M	-$172.04	N/A	N/A	N/A	N/A	-127.39%	-103.77%	8/20/2025 (Estimated)
NUWE Nuwellis	-$20.21M	-$18.24	N/A	N/A	N/A	-169.54%	-28,159.25%	-207.24%	8/12/2025 (Estimated)

Latest ARDM, NDRA, NUWE, and CUTR Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue	Details
5/13/2025	Q1 2025	NUWE Nuwellis	-$0.45	-$0.69	-$0.24	-$0.69	$2.50 million	$1.90 million
3/31/2025	Q4 2024	NDRA ENDRA Life Sciences	-$4.10	-$9.40	-$5.30	-$20.78	N/A	N/A

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
ARDM Aradigm	N/A	N/A	N/A	N/A	N/A
CUTR Cutera	N/A	N/A	N/A	N/A	N/A
NDRA ENDRA Life Sciences	N/A	N/A	N/A	N/A	N/A
NUWE Nuwellis	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
ARDM Aradigm	N/A	1.23	1.23
CUTR Cutera	N/A	2.88	1.86
NDRA ENDRA Life Sciences	N/A	6.10	6.10
NUWE Nuwellis	N/A	2.03	1.34

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
ARDM Aradigm	30.04%
CUTR Cutera	90.70%
NDRA ENDRA Life Sciences	1.19%
NUWE Nuwellis	3.13%

Insider Ownership

Company	Insider Ownership
ARDM Aradigm	4.50%
CUTR Cutera	0.42%
NDRA ENDRA Life Sciences	0.04%
NUWE Nuwellis	1.60%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
ARDM Aradigm	N/A	15.22 million	N/A	Optionable
CUTR Cutera	460	20.19 million	20.10 million	Optionable
NDRA ENDRA Life Sciences	20	738,000	537,000	Not Optionable
NUWE Nuwellis	70	4.37 million	4.26 million	Not Optionable

ARDM, NDRA, NUWE, and CUTR Headlines

Recent News About These Companies

Nuwellis, Inc. Announces Pricing of Public Offering of Common Stock and Warrants

June 11, 2025 | nasdaq.com

Nuwellis announces pricing of $4.3M underwritten public offering

June 11, 2025 | finance.yahoo.com

Nuwellis Announces Closing of $5.0 Million Underwritten Public Offering Including Full Exercise of Overallotment Option

June 10, 2025 | globenewswire.com

Nuwellis Announces Pricing of $4.3 Million Underwritten Public Offering

June 9, 2025 | globenewswire.com

Nuwellis Inc.

June 5, 2025 | barrons.com

Earnings call transcript: Nuwellis Q1 2025 shows growth in revenue, stock stable

May 14, 2025 | investing.com

Nuwellis Inc (NUWE) Q1 2025 Earnings Call Highlights: Strategic Growth Amidst Operational Challenges

May 14, 2025 | finance.yahoo.com

Nuwellis, Inc. (NASDAQ:NUWE) Q1 2025 Earnings Call Transcript

May 14, 2025 | msn.com

Q1 2025 Nuwellis Inc Earnings Call

May 14, 2025 | finance.yahoo.com

Nuwellis, Inc. Partners with KDI Precision Manufacturing to Streamline Operations and Enhance Aquadex Product Manufacturing

May 13, 2025 | nasdaq.com

Nuwellis, Inc. Reports First Quarter 2025 Financial Results and Business Highlights

May 13, 2025 | manilatimes.net

Nuwellis, Inc. (NUWE) Q1 2025 Earnings Call Transcript

May 13, 2025 | seekingalpha.com

Nuwellis, Inc. (NUWE) Reports Q1 Loss, Lags Revenue Estimates

May 13, 2025 | zacks.com

Nuwellis, Inc. Reports First Quarter 2025 Financial Results and Business Highlights

May 13, 2025 | globenewswire.com

Nuwellis, Inc.: Nuwellis Contracts with KDI Precision Manufacturing to Strengthen Production and Improve Operational Efficiency

May 13, 2025 | finanznachrichten.de

Nuwellis Q1 Earnings Preview

May 13, 2025 | msn.com

Nuwellis Contracts with KDI Precision Manufacturing to Strengthen Production and Improve Operational Efficiency

May 12, 2025 | globenewswire.com

Nuwellis Expands Aquadex® for Pediatric Fluid Management to Two New Hospital Systems

May 8, 2025 | globenewswire.com

Nuwellis Expands IP Portfolio with Patent That Reduces Clinical Burden, Preserves Precision

April 24, 2025 | globenewswire.com

Nuwellis, Inc. To Report First Quarter 2025 Financial Results on May 13, 2025

April 22, 2025 | globenewswire.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

ARDM, NDRA, NUWE, and CUTR Company Descriptions

Aradigm NASDAQ:ARDM

Aradigm Corporation, a specialty pharmaceutical company, focuses on the development and commercialization of products for the treatment and prevention of severe respiratory diseases. Its lead development candidates are proprietary formulations of the potent antibiotic ciprofloxacin, including Linhaliq and Lipoquin that are delivered by inhalation for the management of infections associated with severe respiratory diseases, including non-cystic fibrosis bronchiectasis, cystic fibrosis, and non-tuberculosis mycobacterium. The company is also developing inhaled ciprofloxacin formulations for treatment of patients with cystic fibrosis, and has tested for the prevention and treatment of inhaled bioterrorism infections, such as Coxiella burnetii or Q fever, inhalation anthrax, tularemia, melioidosis and pneumonic plague. Aradigm Corporation has collaboration agreements with Grifols, S.A. The company was founded in 1991 and is headquartered in Hayward, California.

Cutera NASDAQ:CUTR

$0.04 -0.07 (-63.86%)

Closing price 03/12/2025

Extended Trading

$0.04 0.00 (0.00%)

As of 03/12/2025 07:59 PM Eastern

Cutera, Inc. provides aesthetic and dermatology solutions for medical practitioners worldwide. It develops, manufactures, and markets energy-based product platforms for medical practitioners; and distributes third-party manufactured skincare products. The company provides AviClear for the treatment of mild, moderate, and severe inflammatory acne vulgaris; Secret PRO, a device that utilizes fractional CO2 for skin resurfacing and radio frequency (RF) microneedling for skin revitalization; truFlex, a bio-electrical muscle stimulation device designs to strengthen, firm and tone the abdomen, buttocks, and thighs; and excel V/V+, a vascular and benign pigmented lesion treatment platform. It also offers truSculpt, a high-powered radio frequency system designed for circumferential reduction, lipolysis, and deep tissue heating and treat all skin types; Secret RF, a fractional RF microneedling device that delivers heat into the deeper layers of the skin using controlled RF energy; and Enlighten SR/III, a laser platform with a dual wavelength for multi-colored tattoo removal, and the treatment of benign pigmented lesions and acne scars. In addition, the company provides Excel HR, a hair removal solution for all skin types; xeo, a multi-application platform for the removal of unwanted hair, treatment of vascular lesions, and skin revitalization by treating discoloration, fine lines, and laxity; and Secret DUO, two dual non-ablative fractional technologies that can be used individually or in combination to target a variety of aesthetic concerns and skin conditions on all skin types with little to no downtime. Further, it offers its products through direct sales and services, and network of distributors and direct international sales. Cutera, Inc. was incorporated in 1998 and is headquartered in Brisbane, California.

ENDRA Life Sciences NASDAQ:NDRA

$3.43 -0.02 (-0.58%)

As of 11:54 AM Eastern

ENDRA Life Sciences Inc. develops technologies to improve the capabilities of clinical diagnostic ultrasound. The company is developing thermo-acoustic enhanced ultrasound technology that uses radio frequency pulses to generate ultrasonic waves in tissue to create high-contrast images for use in the treatment of nonalcoholic fatty liver disease, as well as in tissue composition, temperature monitoring, vascular imaging, and tissue perfusion. It has a collaborative research agreement with General Electric Company. ENDRA Life Sciences Inc. was incorporated in 2007 and is based in Ann Arbor, Michigan.

Nuwellis NASDAQ:NUWE

$0.29 +0.01 (+3.55%)

As of 11:58 AM Eastern

Nuwellis, Inc., a medical device company, develops, manufactures, and commercializes medical devices used in ultrafiltration therapy. The company offers Aquadex FlexFlow and Aquadex SmartFlow systems, which are used to treat patients suffering from fluid overload due to heart failure. Its Aquadex FlexFlow system includes a console, disposable blood circuit set, and disposable catheter. The company sells its products to hospitals and clinics through its direct salesforce in the United States; and through independent specialty distributors in Austria, Belarus, Brazil, Colombia, the Czech Republic, Germany, Greece, Hong Kong, India, Israel, Italy, Panama, Romania, Singapore, Slovakia, Spain, Switzerland, Thailand, the United Arab Emirates, and the United Kingdom. The company was formerly known as CHF Solutions, Inc. and changed its name to Nuwellis, Inc. in April 2021. Nuwellis, Inc. was founded in 1999 and is headquartered in Eden Prairie, Minnesota.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time